MétaCan
Menu
Back to cohort
Record W2591635151

Introduction - 2nd Dubrovnik International Conference on Multiple Sclerosis

2003· article· en· W2591635151 on OpenAlexaboutno aff
Charles M. Poser, Vesna Brinar

Bibliographic record

VenueNeurologia Croatica · 2003
Typearticle
Languageen
FieldMedicine
TopicMultiple Sclerosis Research Studies
Canadian institutionsnot available
Fundersnot available
KeywordsMultiple sclerosisDiseaseMedicineIntensive care medicineEtiologyIdentification (biology)PsychiatryPathologyBiology
DOInot available

Abstract

fetched live from OpenAlex

The past several years have seen a change of emphasis in the meetings devoted to multiple sclerosis (MS) due to the exciting new developments in the long-term treatment of the disease, giving hope to patients, and new therapeutic tools to their neurologists. Nevertheless, many questions remain regarding the exact pathogenesis and etiological factors of the disease. The matter of MS as a single disease, possibly with different pathogenetic mechanisms and/or different phenotypic expressions, or separate disease entities with diverse genetic characteristics, is still unsettled, as is the nosological situation of the eponymic variants of MS, Marburg’ s, Schilder’ s, Balo’ s and Devic’ s diseases. It is abundantly clear that all recurrent demyelinating conditions are not always MS, so that alternative diagnoses must be considered before initiating immunomodulatory or other forms of long-term treatment. Other important questions that remain unanswered are: will it ever be possible to identify families at risk for the disease by means of MRI and/or sophisticated genetic testing? Is there evidence that a pre-disease condition, the “ MS trait” exists and would its identification be the long-sought means for preventing the development of the disease? Discussions of immunomodulatory and other forms of long term treatment are not only understandable, but also most desirable, since a consensus has not yet been reached regarding many of its aspects, such as choice of specific agents, single versus multiple drugs, and optimum dosage and route of administration. An objective critique of the methodology of therapeutic trials should help treating neurologists better appreciate the impact of the available drugs and those still under investigation. The cost of many of these medications remains very high, adding to the already heavy financial burden of the disease itself on health care systems. Not every neurologist believes that all patients with MS should receive one of the available treatments, and a more thorough understanding of the natural history of the disease may prove critical in choosing the right patient for the right drug, or none at all. Some of these issues were addressed during the First International Dubrovnik Conference on MS in May 2001, and will again be examined with the added experience of two more years. We believe that these unresolved questions were sufficient reasons for convening this Second International Dubrovnik Conference on Multiple Sclerosis and inviting distinguished experts from Canada, Croatia, France, Germany, Israel, Poland, Spain, Switzerland, the United Kingdom and the USA to give us the benefit of their knowledge and wisdom.

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame distilled prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. Learned from the 10,348 direct Codex labels and 10,348 direct Gemma labels. Candidate is the union of thresholded teacher heads; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels or direct frontier model labels.

metaresearch head score (Codex)0.000
metaresearch head score (Gemma)0.007
Version: codex-gemma-dda1882f352aValidation status: machine_predicted_unvalidated
Candidate categoriesInsufficient payload (model declined to judge)
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Observational · Consensus signal: none
GenreCandidate signal: Empirical · Consensus signal: Empirical
Teacher disagreement score0.663
Threshold uncertainty score0.998

Codex and Gemma teacher scores by category

CategoryCodexGemma
Metaresearch0.0000.007
Meta-epidemiology (narrow)0.0000.000
Meta-epidemiology (broad)0.0000.000
Bibliometrics0.0000.000
Science and technology studies0.0000.000
Scholarly communication0.0000.000
Open science0.0000.000
Research integrity0.0000.000
Insufficient payload (model declined to judge)0.0020.000

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.117
GPT teacher head0.314
Teacher spread0.197 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one teacher head, not a consensus.

Study designObservational
Domainnot available
GenreEmpirical

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations0
Published2003
Admission routes1
Has abstractyes

Explore more

Same venueNeurologia CroaticaSame topicMultiple Sclerosis Research StudiesFrench-language works237,207